Attached files
| file | filename |
|---|---|
| 10-Q - QUARTERLY REPORT - NUTRA PHARMA CORP | v329535_10q.htm |
| EX-31.1 - EXHIBIT 31.1 - NUTRA PHARMA CORP | v329535_ex31-1.htm |
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of Nutra Pharma Corp., (the "Company") on Form 10-Q for the quarterly period ended June 30, 2012, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Rik Deitsch, the Chief Executive Officer and Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
| 1. | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
| 2. | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
| Dated: December 3, 2012 | |
| /s/ Rik J. Deitsch | |
| Rik J. Deitsch | |
| Chief Executive Officer and Chief Financial Officer |